Point72 Asset Management
GH icon

Point72 Asset Management’s Guardant Health GH Stock Holding History

Point72 Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.3M Sell
695,940
-803,229
-54% -$80.6M 0.08% 282
2025
Q4 		$153M Buy
1,499,169
+1,396,754
+1,364% +$125M 0.17% 97
2025
Q3 		$6.4M Buy
102,415
+46,115
+82% +$2.51M 0.01% 974
2025
Q2 		$2.93M Sell
56,300
-720,270
-93% -$32.2M 0.01% 1159
2025
Q1 		$33.1M Sell
776,570
-96,512
-11% -$4.16M 0.08% 310
2024
Q4 		$26.7M Buy
+873,082
New +$24.6M 0.06% 368
2024
Q3 		– Sell
-1,815,053
Closed -$52.4M – 2119
2024
Q2 		$52.4M Buy
1,815,053
+388,603
+27% +$9.05M 0.14% 206
2024
Q1 		$29.4M Buy
+1,426,450
New +$30.6M 0.07% 329
2023
Q4 		– Sell
-60,879
Closed -$1.6M – 2384
2023
Q3 		$1.8M Sell
60,879
-2,653,406
-98% -$93.3M 0.01% 1161
2023
Q2 		$97.2M Buy
+2,714,285
New +$78M 0.29% 80
2022
Q4 		– Sell
-178,942
Closed -$8.19M – 1613
2022
Q3 		$9.63M Buy
+178,942
New +$9.19M 0.04% 512
2022
Q1 		– Sell
-82,100
Closed -$8.21M – 1244
2021
Q4 		$8.21M Buy
+82,100
New +$8.49M 0.03% 558
2021
Q3 		– Sell
-93,596
Closed -$11.6M – 1117
2021
Q2 		$11.6M Buy
+93,596
New +$12.6M 0.05% 417
2021
Q1 		– Sell
-36,360
Closed -$4.69M – 1037
2020
Q4 		$4.69M Sell
36,360
-154,856
-81% -$17.8M 0.02% 591
2020
Q3 		$21.4M Buy
+191,216
New +$17.5M 0.11% 259
2020
Q1 		– Sell
-94,646
Closed -$7.4M – 887
2019
Q4 		$7.4M Sell
94,646
-670,377
-88% -$48.3M 0.04% 438
2019
Q3 		$48.8M Buy
765,023
+759,442
+13,608% +$66.9M 0.3% 88
2019
Q2 		$482K Buy
5,581
+909
+19% +$69.4K ﹤0.01% 842
2019
Q1 		$358K Buy
+4,672
New +$259K ﹤0.01% 902

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's GH Position: Q1 2026 in Review

Point72 Asset Management reduced its Guardant Health (GH) stake by 54% in Q1 2026, selling an estimated $80.6M and leaving 695,940 shares worth $64.3M. The position accounts for 0.08% of the portfolio, ranked #282.

Point72 Asset Management first reported a position in GH in Q1 2019 and has held it in 19 quarters since. The position peaked at $153M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Point72 Asset Management held 695,940 shares of Guardant Health worth $64.3M as of Q1 2026.
  • Point72 Asset Management sold 803,229 Guardant Health shares in Q1 2026, an estimated $80.6M.
  • Guardant Health made up 0.08% of Point72 Asset Management's portfolio in Q1 2026, its #282 holding.
  • Point72 Asset Management first reported a position in Guardant Health in Q1 2019 and has held it in 19 quarters since.
  • Point72 Asset Management's Guardant Health position peaked at $153M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.